Compare BTU & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BTU | LMAT |
|---|---|---|
| Founded | 2016 | 1983 |
| Country | United States | United States |
| Employees | 6600 | N/A |
| Industry | Coal Mining | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.6B |
| IPO Year | 2001 | 2006 |
| Metric | BTU | LMAT |
|---|---|---|
| Price | $24.07 | $99.38 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 5 |
| Target Price | $32.83 | ★ $105.80 |
| AVG Volume (30 Days) | ★ 2.9M | 201.6K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.09% | 0.93% |
| EPS Growth | N/A | ★ 30.57 |
| EPS | N/A | ★ 0.68 |
| Revenue | ★ $3,861,500,000.00 | $249,602,000.00 |
| Revenue This Year | $17.96 | $14.21 |
| Revenue Next Year | $5.47 | $8.88 |
| P/E Ratio | ★ N/A | $146.38 |
| Revenue Growth | N/A | ★ 13.53 |
| 52 Week Low | $12.62 | $78.35 |
| 52 Week High | $41.14 | $118.01 |
| Indicator | BTU | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 33.70 | 34.25 |
| Support Level | $15.67 | $82.65 |
| Resistance Level | $31.20 | $99.95 |
| Average True Range (ATR) | 1.04 | 5.11 |
| MACD | 0.09 | -1.59 |
| Stochastic Oscillator | 10.33 | 18.93 |
Peabody Energy Corp is a producer of metallurgical and thermal coal. It also markets and brokers coal, both as principal and agent, and trades coal and freight-related contracts. The company operates in the following segment: Seaborne Thermal, Seaborne Metallurgical, Powder River Basin, Other U.S. Thermal and Corporate and Other. The Seaborne Thermal segment generates the majority of the revenue for the company. A substantial part of its overall revenue is generated from its customers in the United States, and rest from Japan, China, Australia, Taiwan, and other regions.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.